Trade CLLS anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Cellectis S.A. American Depositary Shares (CLLS) is trading at US$3.16, down 2.47% today as of Sep 8, 16:00 EDT. The company has a market capitalisation of US$342.89M. Over the past 52 weeks, CLLS has traded between US$2.35 and US$5.48. On Syfe you can trade CLLS with $0 commission and add it to your watchlist.
| Previous close | US$3.24 |
|---|---|
| Market cap | US$342.89M |
| 52-week range | US$2.35 – US$5.48 |
| Volume | 37.47K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Cellectis S.A. American Depositary Shares
Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. Sourdive and André Choulika on February 20, 1999 and is headquartered in Paris, France.
Year: 2015
Cellectis Says Phase 1 Lasme-cel Study Shows 100% Response Rate in B-Cell Leukemia Patients
Jun 11, 3:57 PM · MT Newswires
Cellectis Says US FDA Granted RMAT Designation to Lasme-cel to Treat r/r B-ALL Patients
Jun 9, 8:58 PM · MT Newswires
Stay on top of CLLS
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
